PTCT

PTC THERAPEUTICS INC

Healthcare | Mid Cap

-$0.28

EPS Forecast

$250.6

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.28

Revenue Forecast:

$250.6

EPS Surprise Forecast:

$0.027

Revenue Surprise Forecast:

$14

Post-release price volatility - High

Post-release Overnight Move:

±8.3%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

61%

Probability of beating revenue consensus:

82%

Probability of beating both EPS & revs consensus:

55%

Probability of missing both EPS & revs consensus:

11%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

1.17

Earnings volatility

EPS standard deviation:

$0.31

Revenue standard deviation:

$31

As % of share price:

0.46% HIGH

As % of market cap:

0.56% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.13

Revenue 95th %ile:

$292

EPS 75th %ile:

-$0.17

Revenue 75th %ile:

$262

EPS 25th %ile:

-$0.36

Revenue 25th %ile:

$241

EPS 5th %ile:

-$0.61

Revenue 5th %ile:

$216

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

42% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

35% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$19

Bid-ask per Share:

$0.12